Stay updated on Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    New revision entry v3.5.0 was added to the record history. Revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:55:34.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the history as the latest entry, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:35:40.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study title now specifies Etentamig (ABBV-383) for intravenous use in adults with relapsed or refractory multiple myeloma, with related sections added or updated accordingly.
    Difference
    0.6%
    Check dated 2026-02-18T16:27:40.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    New entry 'Revision: v3.4.2' was added to the record history. A general government operating status notice was removed from deletions.
    Difference
    0.4%
    Check dated 2026-02-11T12:34:29.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The page history shows a site-wide notice about a lapse in government funding and operation status, and an update from Revision: v3.4.0 to v3.4.1; no substantive changes to the study record content were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:53:39.000Z thumbnail image
  9. Check
    77 days ago
    Change Detected
    Summary
    The history page now uses color-coded highlights to differentiate additions and deletions and includes a revision notice (v3.4.0). A glossary toggle to show glossary terms has been added.
    Difference
    0.6%
    Check dated 2026-01-28T04:28:32.000Z thumbnail image

Stay in the know with updates to Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.